MENU
+Compare
DYN
Stock ticker: NASDAQ
AS OF
Jun 12, 11:56 AM (EDT)
Price
$14.29
Change
-$0.29 (-1.99%)
Capitalization
1.66B

DYN Dyne Therapeutics Forecast, Technical & Fundamental Analysis

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DYN with price predictions
Jun 11, 2025

Aroon Indicator for DYN shows an upward move is likely

DYN's Aroon Indicator triggered a bullish signal on June 11, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 206 similar instances where the Aroon Indicator showed a similar pattern. In of the 206 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on DYN as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DYN just turned positive on June 02, 2025. Looking at past instances where DYN's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

DYN moved above its 50-day moving average on May 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DYN advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DYN broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.476) is normal, around the industry mean (16.733). P/E Ratio (0.000) is within average values for comparable stocks, (59.866). DYN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.287). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (259.374).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DYN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DYN is expected to report earnings to fall 10.49% to -93 cents per share on July 31

Dyne Therapeutics DYN Stock Earnings Reports
Q2'25
Est.
$-0.94
Q1'25
Missed
by $0.20
Q4'24
Beat
by $0.06
Q3'24
Missed
by $0.25
Q2'24
Beat
by $0.02
The last earnings report on May 08 showed earnings per share of -104 cents, missing the estimate of -85 cents. With 143.70K shares outstanding, the current market capitalization sits at 1.66B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIDBX25.880.08
+0.31%
American Funds Income Fund of Amer R2
FGSIX66.86N/A
N/A
Federated Hermes MDT Mid Cap Growth IS
NSMVX39.30-0.02
-0.05%
North Star Micro Cap I
LICFX17.01-0.01
-0.06%
Lord Abbett International Equity F
ABCVX22.05-0.06
-0.27%
American Beacon The London Co Inc Eq Inv

DYN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-1.42%
CRNX - DYN
57%
Loosely correlated
-2.27%
XNCR - DYN
52%
Loosely correlated
-2.26%
RNA - DYN
51%
Loosely correlated
-4.79%
ERAS - DYN
51%
Loosely correlated
-5.59%
NTLA - DYN
49%
Loosely correlated
-1.18%
More